Literature DB >> 22689686

Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease.

Yann Lamarre1, Marc Romana, Xavier Waltz, Marie-Laure Lalanne-Mistrih, Benoît Tressières, Lydia Divialle-Doumdo, Marie-Dominique Hardy-Dessources, Jens Vent-Schmidt, Marie Petras, Cedric Broquere, Frederic Maillard, Vanessa Tarer, Maryse Etienne-Julan, Philippe Connes.   

Abstract

BACKGROUND: Little is known about the effects of blood rheology on the occurrence of acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia and hemoglobin SC disease. DESIGN AND METHODS: To address this issue, steady-state hemorheological profiles (blood viscosity, red blood cell deformability, aggregation properties) and hematologic parameters were assessed in 44 children with sickle cell anemia and 49 children with hemoglobin SC disease (8-16 years old) followed since birth. Clinical charts were retrospectively reviewed to determine prior acute chest syndrome or vaso-occlusive episodes, and rates of these complications were calculated.
RESULTS: Multivariate analysis revealed that: 1) a higher steady-state blood viscosity was associated with a higher rate of vaso-occlusive crises in children with sickle cell anemia, but not in children with hemoglobin SC disease; 2) a higher steady-state red blood cell disaggregation threshold was associated with previous history of acute chest syndrome in children with hemoglobin SC disease and boys with sickle cell anemia.
CONCLUSIONS: Our results indicate for the first time that the red blood cell aggregation properties may play a role in the pathophysiology of acute chest syndrome in children with hemoglobin SC disease and boys with sickle cell anemia. In addition, whereas greater blood viscosity is associated with a higher rate of vaso-occlusive crises in children with sickle cell anemia, no association was found in children with hemoglobin SC disease, underscoring differences in the etiology of vaso-occlusive crises between sickle cell anemia and hemoglobin SC disease.

Entities:  

Mesh:

Year:  2012        PMID: 22689686      PMCID: PMC3487435          DOI: 10.3324/haematol.2012.066670

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  28 in total

1.  The Laser-assisted Optical Rotational Cell Analyzer (LORCA) as red blood cell aggregometer.

Authors:  M R Hardeman; J G Dobbe; C Ince
Journal:  Clin Hemorheol Microcirc       Date:  2001       Impact factor: 2.375

2.  A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia.

Authors:  A S Tan; T C Quah; P S Low; S S Chong
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

Review 3.  Blood rheology and hemodynamics.

Authors:  Oguz K Baskurt; Herbert J Meiselman
Journal:  Semin Thromb Hemost       Date:  2003-10       Impact factor: 4.180

4.  Single-tube multiplex-PCR screen for anti-3.7 and anti-4.2 alpha-globin gene triplications.

Authors:  Wen Wang; Edmond S K Ma; Amy Y Y Chan; John Prior; Wendy N Erber; Li C Chan; David H K Chui; Samuel S Chong
Journal:  Clin Chem       Date:  2003-10       Impact factor: 8.327

5.  Rheologic predictors of the severity of the painful sickle cell crisis.

Authors:  S K Ballas; J Larner; E D Smith; S Surrey; E Schwartz; E F Rappaport
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

6.  The incidence of painful crisis in homozygous sickle cell disease: correlation with red cell deformability.

Authors:  W M Lande; D L Andrews; M R Clark; N V Braham; D M Black; S H Embury; W C Mentzer
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

7.  Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors.

Authors:  N Mohandas; E Evans
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

8.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

9.  Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics.

Authors:  Aurélien Pichon; Philippe Connes; Patricia Quidu; Dominique Marchant; Julien Brunet; Bernard I Levy; José Vilar; Innocent Safeukui; Florence Cymbalista; Maxime Maignan; Jean-Paul Richalet; Fabrice Favret
Journal:  Eur Respir J       Date:  2012-04-20       Impact factor: 16.671

Review 10.  The paradox of hemoglobin SC disease.

Authors:  Ronald L Nagel; Mary E Fabry; Martin H Steinberg
Journal:  Blood Rev       Date:  2003-09       Impact factor: 8.250

View more
  36 in total

1.  Microfluidic study of enhanced deposition of sickle cells at acute corners.

Authors:  Etienne Loiseau; Gladys Massiera; Simon Mendez; Patricia Aguilar Martinez; Manouk Abkarian
Journal:  Biophys J       Date:  2015-06-02       Impact factor: 4.033

2.  Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.

Authors:  Nathalie Lemonne; Keyne Charlot; Xavier Waltz; Samir K Ballas; Yann Lamarre; Ketty Lee; Régine Hierso; Catherine Connes; Maryse Etienne-Julan; Marc Romana; Philippe Connes
Journal:  Haematologica       Date:  2015-07-02       Impact factor: 9.941

3.  Hematologic and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell disease.

Authors:  Xavier Waltz; Marc Romana; Marie-Laure Lalanne-Mistrih; Roberto F Machado; Yann Lamarre; Vanessa Tarer; Marie-Dominique Hardy-Dessources; Benoît Tressières; Lydia Divialle-Doumdo; Marie Petras; Frederic Maillard; Maryse Etienne-Julan; Philippe Connes
Journal:  Haematologica       Date:  2013-03-28       Impact factor: 9.941

4.  Impaired blood rheology plays a role in the chronic disorders associated with sickle cell-hemoglobin C disease.

Authors:  Nathalie Lemonne; Yann Lamarre; Marc Romana; Marie-Dominique Hardy-Dessources; François Lionnet; Xavier Waltz; Vanessa Tarer; Danielle Mougenel; Benot Tressières; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Haematologica       Date:  2014-03-14       Impact factor: 9.941

5.  In vitro evidence of complement activation in patients with sickle cell disease.

Authors:  Eleni Gavriilaki; Maria Mainou; Ioanna Christodoulou; Eudoxia-Evaggelia Koravou; Aggeliki Paleta; Tasoula Touloumenidou; Apostolia Papalexandri; Anastasia Athanasiadou; Chrysa Apostolou; Philippos Klonizakis; Achilles Anagnostopoulos; Efthymia Vlachaki
Journal:  Haematologica       Date:  2017-09-14       Impact factor: 9.941

6.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

7.  Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia.

Authors:  Clément Lemaire; Yann Lamarre; Nathalie Lemonne; Xavier Waltz; Sadri Chahed; Florence Cabot; Ioana Botez; Benoit Tressieres; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2013-01-01       Impact factor: 2.375

8.  Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

Authors:  Erik L Bao; Caleb A Lareau; Carlo Brugnara; Isabel R Fulcher; Caroline Barau; Stephane Moutereau; Anoosha Habibi; Bouchra Badaoui; Jugurtha Berkenou; Pablo Bartolucci; Frédéric Galactéros; Orah S Platt; Michael Mahaney; Vijay G Sankaran
Journal:  Am J Hematol       Date:  2019-02-06       Impact factor: 10.047

9.  Erythrocyte Aggregation and Blood Viscosity is Similar in Homozygous Sickle Cell Disease Patients with and without Leg Ulcers.

Authors:  Andre S A Bowers; Walworth W Duncan; D J Pepple
Journal:  Int J Angiol       Date:  2018-02-09

10.  Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease.

Authors:  Yann Lamarre; Marie-Dominique Hardy-Dessources; Marc Romana; Marie-Laure Lalanne-Mistrih; Xavier Waltz; Marie Petras; Lydia Doumdo; Anne Blanchet-Deverly; Jean Martino; Benoît Tressières; Frederic Maillard; Vanessa Tarer; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.